TY - JOUR
T1 - Characteristics and outcomes of bacteremia among ICU-admitted patients with severe sepsis
AU - JAAM FORECAST group
AU - Komori, Akira
AU - Abe, Toshikazu
AU - Kushimoto, Shigeki
AU - Ogura, Hiroshi
AU - Shiraishi, Atsushi
AU - Saitoh, Daizoh
AU - Fujishima, Seitaro
AU - Mayumi, Toshihiko
AU - Naito, Toshio
AU - Hifumi, Toru
AU - Shiino, Yasukazu
AU - Nakada, Taka aki
AU - Tarui, Takehiko
AU - Otomo, Yasuhiro
AU - Okamoto, Kohji
AU - Umemura, Yutaka
AU - Kotani, Joji
AU - Sakamoto, Yuichiro
AU - Sasaki, Junichi
AU - Shiraishi, Shin ichiro
AU - Takuma, Kiyotsugu
AU - Tsuruta, Ryosuke
AU - Hagiwara, Akiyoshi
AU - Yamakawa, Kazuma
AU - Masuno, Tomohiko
AU - Takeyama, Naoshi
AU - Yamashita, Norio
AU - Ikeda, Hiroto
AU - Ueyama, Masashi
AU - Fujimi, Satoshi
AU - Gando, Satoshi
AU - Tasaki, Osamu
AU - Mizobata, Yasumitsu
AU - Funakoshi, Hiraku
AU - Okuyama, Toshiro
AU - Yamashita, Iwao
AU - Kanai, Toshio
AU - Yamada, Yasuo
AU - Aibiki, Mayuki
AU - Sato, Keiji
AU - Yamashita, Susumu
AU - Yoshida, Kenichi
AU - Kasaoka, Shunji
AU - Kon, Akihide
AU - Rinka, Hiroshi
AU - Kato, Hiroshi
AU - Okudera, Hiroshi
AU - Narimatsu, Eichi
AU - Fujiwara, Toshifumi
AU - Sugita, Manabu
N1 - Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12/1
Y1 - 2020/12/1
N2 - The clinical implications of bacteremia among septic patients remain unclear, although a vast amount of data have been accumulated on sepsis. We aimed to compare the clinical characteristics and outcomes of severe sepsis patients with and without bacteremia. This secondary analysis of a multicenter, prospective cohort study included 59 intensive care units (ICUs) in Japan between January 2016 and March 2017. The study cohort comprised 1,184 adults (aged ≥ 16 years) who were admitted to an ICU with severe sepsis and diagnosed according to the Sepsis-2 criteria. Of 1,167 patients included in the analysis, 636 (54.5%) had bacteremia. Those with bacteremia had significantly higher rates of septic shock (66.4% vs. 58.9%, p = 0.01) and higher sepsis severity scores, including the Acute Physiology and Chronic Health Evaluation (APACHE) II and the Sequential Organ Failure Assessment (SOFA). No significant difference in in-hospital mortality was seen between patients with and without bacteremia (25.6% vs. 21.0%, p = 0.08). In conclusion, half of severe sepsis patients in ICUs have bacteremia. Although patients with bacteremia had more severe state, between-group differences in patient-centered outcomes, such as in-hospital mortality, have not been fully elucidated.
AB - The clinical implications of bacteremia among septic patients remain unclear, although a vast amount of data have been accumulated on sepsis. We aimed to compare the clinical characteristics and outcomes of severe sepsis patients with and without bacteremia. This secondary analysis of a multicenter, prospective cohort study included 59 intensive care units (ICUs) in Japan between January 2016 and March 2017. The study cohort comprised 1,184 adults (aged ≥ 16 years) who were admitted to an ICU with severe sepsis and diagnosed according to the Sepsis-2 criteria. Of 1,167 patients included in the analysis, 636 (54.5%) had bacteremia. Those with bacteremia had significantly higher rates of septic shock (66.4% vs. 58.9%, p = 0.01) and higher sepsis severity scores, including the Acute Physiology and Chronic Health Evaluation (APACHE) II and the Sequential Organ Failure Assessment (SOFA). No significant difference in in-hospital mortality was seen between patients with and without bacteremia (25.6% vs. 21.0%, p = 0.08). In conclusion, half of severe sepsis patients in ICUs have bacteremia. Although patients with bacteremia had more severe state, between-group differences in patient-centered outcomes, such as in-hospital mortality, have not been fully elucidated.
UR - http://www.scopus.com/inward/record.url?scp=85079815814&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079815814&partnerID=8YFLogxK
U2 - 10.1038/s41598-020-59830-6
DO - 10.1038/s41598-020-59830-6
M3 - Article
C2 - 32076046
AN - SCOPUS:85079815814
SN - 2045-2322
VL - 10
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 2983
ER -